Skip header and navigation

33 records – page 1 of 2.

Day surgery peritoneal dialysis catheter insertion

https://libcat.nshealth.ca/en/permalink/chpams35158
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1226
Available Online
View Pamphlet
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (18 p.) : digital, PDF file
Subjects (MeSH)
Hospital admission
Peritoneal dialysis
Kidney Diseases - surgery
Preoperative Care
Postoperative Care
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Preoperative care
Postoperative care
Specialty
Nephrology
Hematology
Abstract
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
Responsibility
prepared by: NSHA Renal Program
Pamphlet Number
1226
Less detail

24-hour urine collection : split daytime and nightime

https://libcat.nshealth.ca/en/permalink/chpams36496
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1940
Available Online
View Pamphlet
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Urine Specimen Collection
Specimen Handling
Subjects (LCSH)
Diagnostic specimens
Urine--Collection and preservation
Abstract
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1940
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Care of your peritoneal dialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams36677
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0352
Available Online
View Pamphlet
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Kidney Diseases - surgery
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Specialty
Nephrology
Hematology
Abstract
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
0352
Less detail

Prendre soin de votre cathéter de dialyse péritonéale

https://libcat.nshealth.ca/en/permalink/chpams36721
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2098
Available Online
View Pamphlet
La brochure porte sur la façon de protéger votre cathéter de dialyse péritonéale. On y traite des soins de l’incision (coupure) ou du point d'émergence cutané (point de sortie) après l’opération et du maintien de la régularité intestinale. On vous indique aussi quand appeler l’infirmière de l’Ordre de Victoria du Canada (VON) ou des soins à domicile. ; This pamphlet is a French translation of "Care of Your Peritoneal Dialysis Catheter" pamphlet 0352. This pamphlet reviews how to protect your pe…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Care of your peritoneal dialysis catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Kidney Diseases - surgery
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Specialty
Nephrology
Hematology
Abstract
La brochure porte sur la façon de protéger votre cathéter de dialyse péritonéale. On y traite des soins de l’incision (coupure) ou du point d'émergence cutané (point de sortie) après l’opération et du maintien de la régularité intestinale. On vous indique aussi quand appeler l’infirmière de l’Ordre de Victoria du Canada (VON) ou des soins à domicile.
This pamphlet is a French translation of "Care of Your Peritoneal Dialysis Catheter" pamphlet 0352. This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2098
Less detail

Fer injectable et insuffisance rénale chronique (IRC)

https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2161
Available Online
View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Injectable iron and chronic kidney disease (CKD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2161
Less detail

How to do a twin bag exchange

https://libcat.nshealth.ca/en/permalink/chpams34482
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0633
Available Online
View Pamphlet
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0633
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams37434
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2214
Available Online
View Pamphlet
This pamphlet is a Simplified Chinese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Simplified Chinese
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Simplified Chinese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2214
Less detail

Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2217
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully consider the risks and benefits of ESAs. The risks and benefits of ESAs are listed. Your health care team will talk with you about the risks and benefits of ESAs and other factors to consider when making the decision to take ESAs.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams38239
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2379
Available Online
View Pamphlet
This pamphlet is a Russian translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Russian
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Russian translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2379
Less detail

[How to do a twin bag exchange]

https://libcat.nshealth.ca/en/permalink/chpams38262
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2390
Available Online
View Pamphlet
This pamphlet is a Vietnamese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
Vietnamese
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet is a Vietnamese translation of the English pamphlet 0633, "How to do a Twin Bag™ Exchange". This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2390
Less detail
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0397
Available Online
View Pamphlet
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Fistula - radiography
Balloon Occlusion
Radiography, Interventional - methods
Subjects (LCSH)
Fistula
Therapeutic embolization
Specialty
Nephrology
Abstract
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0397
Less detail

Tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35616
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1032
Available Online
View Pamphlet
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Hemodialysis
Catheters
Specialty
Nephrology
Abstract
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1032
Less detail

Non-tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35618
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1093
Available Online
View Pamphlet
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Catheters
Hemodialysis
Specialty
Nephrology
Abstract
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1093
Less detail

Care of your arteriovenous fistula

https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0651
Available Online
View Pamphlet
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Central Venous Catheters
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Specialty
Nephrology
Abstract
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0651
Less detail

Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1889
Available Online
View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Str…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Heptavalent Pneumococcal Conjugate Vaccine
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1889
Less detail

Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1890
Less detail

Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2307
Available Online
View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Subjects (LCSH)
Kidneys--Diseases--Treatment
Specialty
Nephrology
Medications
Abstract
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2307
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

33 records – page 1 of 2.